GLP-1 (Glucagon-like peptide-1) is an incretin secreted from intestinal L cells
Katie Drakeford, MA, RD, CSP, LD, CLC Author Katie Drakeford, MA, RD, LD, is registered dietitian with over 14 years of experience working with people of all ages to improve their health through nutrition

Nadolsky became a physician: (2:004:13) What is cardiometabolic medicine?: (4:135:17) What is a healthy metabolism?: (5:177:37) How does diet impact glucose regulation: (7:3710:20) Why has insulin resistance increased in the past decade?: (10:2011:45) Ethnicity impacts BMI cutoffs: (11:4512:57) Is obesity a choice?: (12:5717:40) How socioeconomic status impacts obesity: (17:4021:30) What's better: A BMI score or a DEXA scan?: (21:3025:33) How strength training improves healthspan: (25:3332:32) What a fasting insulin blood test tells you: (32:3236:58) Health risks of insulin resistance: (35:1538:08) How insulin resistance can increase ApoB: (38:0839:25) How does ApoB predict heart disease risk?: (39:2542:50) Why isn't ApoB included in typical lipid panels?: (42:5044:25) Behavioral science and clinical practice: (44:2550:06) How do GLP-1 agonists cause weight loss
Likely because it's still an emerging field of research
The choice between a tirzepatide-based or semaglutide-based blend depends on factors beyond the L-carnitine addition, including which GLP-1 your body responds to better, side effect tolerance, cost, and prescriber preference
MPC Pharma Pvt Ltd serves most of the major hospitals, pharmacies and healthcare sectors in India